Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KeraNetics is a clinical-stage biotechnology company focused on developing regenerative medicine products based on a proprietary purified keratin technology platform. The company utilizes human hair-derived keratin proteins to create biomaterials that promote tissue repair and regeneration across a variety of medical applications, including trauma, surgery, and chronic wound care. Their product pipeline includes solutions for volumetric muscle loss, radiation dermatitis, and bone healing, often supported by significant funding from the Department of Defense and the NIH. KeraNetics aims to provide biocompatible, non-immunogenic scaffolds that facilitate the body's natural healing processes in both military and civilian healthcare settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keratin Biosciences.